Stock Analysis

Brookfield Full Year 2024 Earnings: EPS: US$0.31 (vs US$0.62 in FY 2023)

TSX:BN
Source: Shutterstock

Brookfield (TSE:BN) Full Year 2024 Results

Key Financial Results

  • Revenue: US$90.0b (down 8.2% from FY 2023).
  • Net income: US$641.0m (down 34% from FY 2023).
  • Profit margin: 0.7% (down from 1.0% in FY 2023). The decrease in margin was driven by lower revenue.
  • EPS: US$0.31 (down from US$0.62 in FY 2023).
earnings-and-revenue-history
TSX:BN Earnings and Revenue History February 14th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Brookfield Earnings Insights

Looking ahead, revenue is expected to fall by 86% p.a. on average during the next 3 years compared to a 10% decline forecast for the Capital Markets industry in Canada.

Performance of the Canadian Capital Markets industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for Brookfield you should be aware of, and 2 of them are potentially serious.

Valuation is complex, but we're here to simplify it.

Discover if Brookfield might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSX:BN

Brookfield

An alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets.

Low with poor track record.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|36.403% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|25.014999999999997% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|4.1226% overvalued
Jonataninho
Jonataninho
Community Contributor